tert-Butyl (6-methyl-5-nitropyridin-2-yl)carbamate, 98%, 5g

3-BROMO-5-FLUORO-2-METHYL PYRIDINE, 97.0%, 5g

1,3-Bis(2-hydroxyethoxy)benzene>98.0%(GC)25g

Methyl 3-bromo-4-fluoro-5-nitrobenzoate, 98%, 1g

(R)-3-(7-cyano-5-(2-((2-(2-(2,2,2-trifluoroethoxy)phenoxy)ethyl)amino)propyl)indolin-1-yl)propyl benzoate oxalate, 97%, 250mg

Viales de centelleo, 20 ml, 1000 Unidad(es)

(1-Ethyl-3,5-dimethyl-1H-pyrazol-4-yl)-methanol, 95.0%, 10g

9-(2-Ethylhexyl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-9H-carbazole>98.0%(HPLC)1g

1-Methyl-4-(methylamino)piperidine, 98.0%, 10g

n-Methylpyrrolidine-2-carboxamide hydrochloride, 95+%, 500mg

Methyl (1R,2S,5S)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxylate (2S,3S)-2,3-bis(benzoyloxy)succinate, 97%, 100mg

1-ETHYL-4-OXO-7-(4-PYRIDYL)-1,4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID, 95%, 100mg

3-Bromo-5-(tert-butyl)aniline, 98%, 1g